Cat: IPD-X13532

Recombinant Rat MIP-3 alpha/CCL20 Protein(HEK293)

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    MIP-3 alpha/CCL20

  • 简介

    MIP-3 alpha/CCL20 Protein, Rat (HEK293) is a CC chemokine that attracts lymphocytes and mild neutrophils by binding to and acting on the chemokine receptor CCR6. It induces intracellular calcium mobilization and mediates cancer, various autoimmune diseases, and antimicrobial effects. MIP-3 alpha/CCL20 Protein, Rat (HEK293) is a recombinant rat CCL20 (A26-M96) expressed by HEK293 cells[1].

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    Measured by its ability to chemoattract BaF3 mouse pro B cells transfected with human CCR6. The ED50 for this effect is 1.739 μg/mL, corresponding to a specific activity is 575.043 U/mg. Measured by its ability to chemoattract THP-1 human acute monocytic leukemia cells. The ED50 for this effect is 32.76 ng/mL, corresponding to a specific activity is 3.052×104 U/mg.

  • Alternative Names

    rRtMIP-3α/CCL20; C-C motif chemokine 20; MIP3A; SCYA20

  • Species

    Rat

  • Source

    HEK293

  • Tag

    Tag Free

  • Purity

    Greater than 95% as determined by reducing SDS-PAGE.

  • Uniprot

    P97884

  • Expression Region

    A26-M96

  • Protein Length

    Partial

  • Molecular Weight

    10 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

MIP-3 alpha, also known as CCL20, is a chemokine that plays a crucial role in immune responses by attracting specific types of immune cells, notably CD4+ T lymphocytes and dendritic cells, to sites of inflammation. It is primarily produced by epithelial and endothelial cells in response to various stimuli, including infections and inflammatory cytokines. The significance of CCL20 in the pathogenesis of several diseases, particularly in autoimmune conditions, cancer, and chronic inflammatory disorders, has spurred considerable research interest. Understanding the mechanisms by which CCL20 mediates immune cell migration and its interactions with CCR6, its sole receptor, is vital for unraveling its role in both health and disease. To investigate these processes, researchers have developed recombinant CCL20 proteins, which facilitate the exploration of its biological functions, signaling pathways, and potential therapeutic applications. By utilizing recombinant technology, scientists aim to determine how CCL20 contributes to disease progression and assess its utility as a target for drug development, potentially leading to novel treatments for conditions characterized by dysregulated immune responses. The ongoing studies on MIP-3 alpha/CCL20 continue to enhance our understanding of immune system dynamics and open new avenues for intervention in disease management.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US